Cancer News: Breast

A diagnosis of high cholesterol led to increased cancer survival

A diagnosis of high cholesterol led to reduced mortality and improved survival in lung, breast, prostate and bowel cancer, a new researches reveals.

Fewer memory problems for breast cancer survivors who exercise

Physical activity improved subjective memory in breast cancer survivors, alleviating stress, a new study reports.

Acupressure helps breast cancer survivors deal with fatigue

Breast cancer survivors who did acupressure over six weeks reduced fatigue, the most common long-term effects of breast cancer treatment.

Smoking reduced the benefit of common breast cancer treatment

Breast cancer patients treated with aromatase inhibitors who continued smoking had a three times higher risk of recurrence of breast cancer, a study shows.

Breast conserving therapy Vs mastectomy in early breast cancer

Breast conserving therapy was associated with a higher risk of metastasis compared to mastectomy in early breast cancer patients, younger than 45 years old.

Is shorter radiation better for early breast cancer patients?

Treating early breast cancer patients with a shorter course of whole breast radiation induced the same outcomes as the longer course, a study reveals.

Breast cancer: lower risk of recurrence with hormone therapy

Postmenopausal breast cancer patients had a 34% lower risk of recurrence after receiving hormone therapy letrozole from 5 to 10 years, a new study shows.

Tackling chemo side effects with personalized exercise program

Exercise reduced symptoms of neuropathy due to chemotherapy in cancer patients, investigators report.

Early positive results for Novartis breast cancer drug

Novartis halted early the clinical trial of the experimental breast cancer drug LEE011 in combination with letrozole due to positive results, the company announced.

Positive results from Keytruda in triple-negative breast cancer

Pembrolizumab (Keytruda) induced promising clinical activity in heavily pretreated patients with advanced triple-negative breast cancer.

Avastin combo improves survival in advanced breast cancer

A breast cancer combination treatment improved progression-free survival but not other outcomes, a new phase 3 study showed.

Breast cancer surgery: does the patient’s age affect the outcomes?

The patient’s age and the type of breast cancer surgery affects the outcomes in breast cancer patients, a new Danish study reveals.

Newer hormone therapy doesn’t increase heart risk in breast cancer

Breast cancer patients treated with aromatase inhibitors, hormone-therapy drugs, were not in increased risk of fatal cardiovascular events, new study reports.

Heart surveillance: necessary after herceptin in breast cancer

Monitoring for heart damage should be regular in breast cancer patients undergoing treatment with trastuzumab-containing regimens, a new study says.

Low fat diet increased survival in breast cancer patients

Following a low fat diet increased breast cancer overall survival from diagnosis in postmenopausal women, a new study finds.

Is delayed radiation harmful for women with breast abnormality?

Women treated for ductal carcinoma in situ (DCIS) receiving delayed radiation treatment were at risk developing malignant breast tumors, a new study shows.

Aromasin demonstrates efficacy against breast cancer recurrence

Exemestane (Aromasin) plus ovarian function suppression (OFS) proved to be more beneficial for breast cancer patients than tamoxifen with or without OFS.

Healthy breast removal won’t increase survival in breast cancer

Removing the second, healthy breast rose from 4% in breast cancer patients in 2002 to nearly 13% in 2012. However, this removal will not reduce the risk of dying.

Genomic test helps early breast cancer patients avoid chemo

Genomic testing can be used to help accurately select early breast cancer patients who can safely be spared chemotherapy, a new study shows.

Improved survival in breast cancer with 'dose-dense' chemo

A meta-analysis revealed that dose-dense adjuvant chemotherapy significantly improved overall survival in premenopausal women with breast cancer.

Breast cancer tumors shrunk with lapatinib and trastuzumab combo

Tumors of breast cancer patients either shrunk or disappeared after treatment with a combination of lapatinib and trastuzumab.

Less breast cancer side effects with partial radiotherapy

Focusing postoperative radiotherapy around tumor containing cells has fewer long-term side effects and low recurrence rate in breast cancer patients.

Linking early stage breast cancer and high white blood cell ratio

A retrospective study reports that a high white blood cell ratio in early stage breast cancer patients is linked to an increased risk of disease recurrence.

Double mastectomy: not the best option for breast cancer patients

A new study reports that undergoing double mastectomy did not improve the quality of life of breast cancer patients.

Childhood Hodgkin's lymphoma survivors are at risk of breast cancer

Childhood Hodgkin's lymphoma survivors are at risk of breast cancer say researchers, adding that early screening reduces risk of breast cancer death.

Palbociclib gets early FDA approval for breast cancer

US regulators approved earlier than scheduled palbociclib in combination with fulvestrant for the treatment of some cases of breast cancer.

Risk link identified between breast and thyroid cancer survivors

Breast or thyroid cancer survivors are more likely to develop the other type later in life compared to women with no breast or thyroid cancer history.

Breast reconstruction with fat injection: safe in breast cancer

Breast reconstruction with fat injection proved to be safe for women with recurrent breast cancer, according to a new study.

Why should breast cancer patients quit smoking?

One large study assessing breast cancer survivors’ smoking habits both before and after diagnosis reports that quitting smoking after diagnosis lowers risk of death.

Breast cancer may come back even after 24 years

A new analysis reveals that ER-positive (ER+) breast cancer may return even after more than 24 years of follow-up.

Login to your account

Did you forget your password?